EP 27
Unlocking Secrets of the Body: Peptides, AI Injury Diagnosis, and Magnetic Pigeons
About this episode
The docs return from a break to talk work-life balance for busy physician dads, then dive deep into peptides like BPC-157 being moved off FDA Category 2, the July 23rd PCAC vote, and RFK Jr.'s push to allow compounding. They explore patients fact-checking doctors with ChatGPT and Claude, GLP-1 obesity-prevention trials, why exercise still beats injectables, and a wild study showing homing pigeons navigate using iron-rich macrophages in their liver as a magnetic compass.
What we cover in this episode
- physician work-life balance and burnout as dads
- patients using ChatGPT and Claude to question their doctors
- BPC-157 and peptides moved off FDA Category 2
- RFK Jr and the PCAC vote on compounding peptides
- 503A vs 503B compounding pharmacies explained
- GLP-1 drugs for obesity prevention in healthy patients
- why exercise beats peptide and GLP-1 injections
- how much exercise sedentary people actually need
- magnetic pigeons navigating with iron in the liver
- concierge primary care vs traditional PCP
Your hosts
Dr. Humayun NaqviPreventive Cardiologist · West Houston Heart Center
Dr. Adil AhmedOrthopedic Surgeon · Baylor College of Medicine